Contrast-enhanced CT of small hypovascular hepatic tumors

Effect of lesion enhancement on conspicuity in rabbits

Brian S. Kuszyk, David A. Bluemke, Michael A. Choti, Karen M. Horton, Carolyn A. Magee, Elliot K. Fishman

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

OBJECTIVE. The purpose of this study was to evaluate the effect of lesion enhancement on the conspicuity of small hypovascular hepatic tumors in an animal model. MATERIALS AND METHODS. Seven VX2 hepatic tumors in five rabbits were imaged. Dynamic contrast-enhanced CT was performed at a single level centered over the lesions at 5-sec intervals for 119 sec after injection of 2 ml/kg IV contrast material at 2 ml/sec. Attenuation was measured over time within regions of interest in the tumor and normal liver, aorta, inferior vena cava, and portal vein. Lesion conspicuity, defined as the difference between the attenuation of the uninvolved liver and neoplasm, was calculated. RESULTS. The mean diameter of the tumors on CT was 10 mm (range, 6-15 mm). The tumors appeared as low-attenuation lesions with progressive enhancement during the arterial phase and early portal phase. Peak mean lesion attenuation was 60 ± 27 H (enhancement, 23 H) at 64 sec. Peak mean lesion conspicuity was 80 ± 18 H at 39 sec, occurring 10 sec before the peak mean hepatic attenuation of 135 ± 15 H (enhancement, 67 H) at 49 sec. Relative lesion conspicuity paralleled relative enhancement of the liver throughout the imaging period. CONCLUSION. Although low-level tumor enhancement during the arterial phase and early portal phase reduced the conspicuity of small hypovascular tumors in this animal model, our results support the use of maximum liver enhancement as a marker for peak lesion conspicuity.

Original languageEnglish (US)
Pages (from-to)471-475
Number of pages5
JournalAmerican Journal of Roentgenology
Volume174
Issue number2
StatePublished - Feb 2000

Fingerprint

Rabbits
Liver
Neoplasms
Animal Models
Inferior Vena Cava
Liver Neoplasms
Portal Vein
Contrast Media
Aorta
Injections

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Contrast-enhanced CT of small hypovascular hepatic tumors : Effect of lesion enhancement on conspicuity in rabbits. / Kuszyk, Brian S.; Bluemke, David A.; Choti, Michael A.; Horton, Karen M.; Magee, Carolyn A.; Fishman, Elliot K.

In: American Journal of Roentgenology, Vol. 174, No. 2, 02.2000, p. 471-475.

Research output: Contribution to journalArticle

Kuszyk, Brian S. ; Bluemke, David A. ; Choti, Michael A. ; Horton, Karen M. ; Magee, Carolyn A. ; Fishman, Elliot K. / Contrast-enhanced CT of small hypovascular hepatic tumors : Effect of lesion enhancement on conspicuity in rabbits. In: American Journal of Roentgenology. 2000 ; Vol. 174, No. 2. pp. 471-475.
@article{346c9bf64f6a4640a868c02b92a5d8db,
title = "Contrast-enhanced CT of small hypovascular hepatic tumors: Effect of lesion enhancement on conspicuity in rabbits",
abstract = "OBJECTIVE. The purpose of this study was to evaluate the effect of lesion enhancement on the conspicuity of small hypovascular hepatic tumors in an animal model. MATERIALS AND METHODS. Seven VX2 hepatic tumors in five rabbits were imaged. Dynamic contrast-enhanced CT was performed at a single level centered over the lesions at 5-sec intervals for 119 sec after injection of 2 ml/kg IV contrast material at 2 ml/sec. Attenuation was measured over time within regions of interest in the tumor and normal liver, aorta, inferior vena cava, and portal vein. Lesion conspicuity, defined as the difference between the attenuation of the uninvolved liver and neoplasm, was calculated. RESULTS. The mean diameter of the tumors on CT was 10 mm (range, 6-15 mm). The tumors appeared as low-attenuation lesions with progressive enhancement during the arterial phase and early portal phase. Peak mean lesion attenuation was 60 ± 27 H (enhancement, 23 H) at 64 sec. Peak mean lesion conspicuity was 80 ± 18 H at 39 sec, occurring 10 sec before the peak mean hepatic attenuation of 135 ± 15 H (enhancement, 67 H) at 49 sec. Relative lesion conspicuity paralleled relative enhancement of the liver throughout the imaging period. CONCLUSION. Although low-level tumor enhancement during the arterial phase and early portal phase reduced the conspicuity of small hypovascular tumors in this animal model, our results support the use of maximum liver enhancement as a marker for peak lesion conspicuity.",
author = "Kuszyk, {Brian S.} and Bluemke, {David A.} and Choti, {Michael A.} and Horton, {Karen M.} and Magee, {Carolyn A.} and Fishman, {Elliot K.}",
year = "2000",
month = "2",
language = "English (US)",
volume = "174",
pages = "471--475",
journal = "American Journal of Roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "2",

}

TY - JOUR

T1 - Contrast-enhanced CT of small hypovascular hepatic tumors

T2 - Effect of lesion enhancement on conspicuity in rabbits

AU - Kuszyk, Brian S.

AU - Bluemke, David A.

AU - Choti, Michael A.

AU - Horton, Karen M.

AU - Magee, Carolyn A.

AU - Fishman, Elliot K.

PY - 2000/2

Y1 - 2000/2

N2 - OBJECTIVE. The purpose of this study was to evaluate the effect of lesion enhancement on the conspicuity of small hypovascular hepatic tumors in an animal model. MATERIALS AND METHODS. Seven VX2 hepatic tumors in five rabbits were imaged. Dynamic contrast-enhanced CT was performed at a single level centered over the lesions at 5-sec intervals for 119 sec after injection of 2 ml/kg IV contrast material at 2 ml/sec. Attenuation was measured over time within regions of interest in the tumor and normal liver, aorta, inferior vena cava, and portal vein. Lesion conspicuity, defined as the difference between the attenuation of the uninvolved liver and neoplasm, was calculated. RESULTS. The mean diameter of the tumors on CT was 10 mm (range, 6-15 mm). The tumors appeared as low-attenuation lesions with progressive enhancement during the arterial phase and early portal phase. Peak mean lesion attenuation was 60 ± 27 H (enhancement, 23 H) at 64 sec. Peak mean lesion conspicuity was 80 ± 18 H at 39 sec, occurring 10 sec before the peak mean hepatic attenuation of 135 ± 15 H (enhancement, 67 H) at 49 sec. Relative lesion conspicuity paralleled relative enhancement of the liver throughout the imaging period. CONCLUSION. Although low-level tumor enhancement during the arterial phase and early portal phase reduced the conspicuity of small hypovascular tumors in this animal model, our results support the use of maximum liver enhancement as a marker for peak lesion conspicuity.

AB - OBJECTIVE. The purpose of this study was to evaluate the effect of lesion enhancement on the conspicuity of small hypovascular hepatic tumors in an animal model. MATERIALS AND METHODS. Seven VX2 hepatic tumors in five rabbits were imaged. Dynamic contrast-enhanced CT was performed at a single level centered over the lesions at 5-sec intervals for 119 sec after injection of 2 ml/kg IV contrast material at 2 ml/sec. Attenuation was measured over time within regions of interest in the tumor and normal liver, aorta, inferior vena cava, and portal vein. Lesion conspicuity, defined as the difference between the attenuation of the uninvolved liver and neoplasm, was calculated. RESULTS. The mean diameter of the tumors on CT was 10 mm (range, 6-15 mm). The tumors appeared as low-attenuation lesions with progressive enhancement during the arterial phase and early portal phase. Peak mean lesion attenuation was 60 ± 27 H (enhancement, 23 H) at 64 sec. Peak mean lesion conspicuity was 80 ± 18 H at 39 sec, occurring 10 sec before the peak mean hepatic attenuation of 135 ± 15 H (enhancement, 67 H) at 49 sec. Relative lesion conspicuity paralleled relative enhancement of the liver throughout the imaging period. CONCLUSION. Although low-level tumor enhancement during the arterial phase and early portal phase reduced the conspicuity of small hypovascular tumors in this animal model, our results support the use of maximum liver enhancement as a marker for peak lesion conspicuity.

UR - http://www.scopus.com/inward/record.url?scp=0343920769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0343920769&partnerID=8YFLogxK

M3 - Article

VL - 174

SP - 471

EP - 475

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

SN - 0361-803X

IS - 2

ER -